TAXUS® Liberté® Atom™ Paclitaxel-Eluting Coronary Stent System

Advancing design for drug delivery in small vessels

Introducing the TAXUS Liberté Atom Stent System, a 2.25mm drug-eluting stent (DES) engineered specifically for consistent drug delivery in small vessels.

The TAXUS Liberté Atom Stent expands your small vessel treatment options with improved deliverability and efficacy.*

*As compared to the TAXUS® Express²® Atom Stent System. Data on file.

Engineered for Consistent Drug Distribution

• Unique, uniform repeating cell geometry supports even drug distribution and delivery
• Hybrid cell design allows for strength, flexibility and conformability

Designed for Improved Deliverability in Small Vessels**

• 27% thinner struts (0.0038")**
• Lowest stent crossing profile (0.041")
• Lowest tip profile (0.017")
• 13% more trackable stent delivery system**

*Computer modeling of drug distribution uniformity in vascular tissue. Modeling results are for demonstration purposes only and may not necessarily be indicative of clinical performance. Testing completed by Boston Scientific Corporation. Data on file.
**As compared to the TAXUS® Express²® Atom Stent System. Data on file.

Customized to Accommodate Small Vessels

• Dedicated small vessel stent model (2.25-2.50mm)
• Stent delivery system sized for a 2.25mm vessel

Advancing efficacy and safety in small vessels

In the TAXUS ATLAS SV Trial, the primary endpoint of 9-month analysis segment Percent Diameter Stenosis was statistically significantly smaller in the TAXUS Liberté Atom Stent group versus the DES Control Group (32.09±18.38mm versus 38.36±23.64mm respectively, p=0.0351).

*MACE: Cardiac Death, MI and TVR.
**As compared to the TAXUS Express² Atom Stent System. Data on file.

TAXUS Liberté Atom Stent Size Matrix

Boston Scientific continues to offer the largest selection of drug-eluting stents. The newly expanded size matrix for the TAXUS Liberté Atom Stent features the longest and thinnest
≥2.25mm drug-eluting stent approved by the FDA.